JP2015505831A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015505831A5 JP2015505831A5 JP2014544964A JP2014544964A JP2015505831A5 JP 2015505831 A5 JP2015505831 A5 JP 2015505831A5 JP 2014544964 A JP2014544964 A JP 2014544964A JP 2014544964 A JP2014544964 A JP 2014544964A JP 2015505831 A5 JP2015505831 A5 JP 2015505831A5
- Authority
- JP
- Japan
- Prior art keywords
- mutant
- leukocidin
- subunit
- seq
- subunit polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566234P | 2011-12-02 | 2011-12-02 | |
| US61/566,234 | 2011-12-02 | ||
| PCT/US2012/067483 WO2013082558A1 (en) | 2011-12-02 | 2012-11-30 | Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015505831A JP2015505831A (ja) | 2015-02-26 |
| JP2015505831A5 true JP2015505831A5 (cg-RX-API-DMAC7.html) | 2016-01-28 |
| JP6325452B2 JP6325452B2 (ja) | 2018-05-16 |
Family
ID=48536149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014544964A Active JP6325452B2 (ja) | 2011-12-02 | 2012-11-30 | パントンバレンタインロイコシジン（ｐｖｌ）由来ポリペプチドを含む免疫原性組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10023848B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2785368B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6325452B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101999299B1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012345645B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2857666C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2785368T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2728445T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20190907T1 (cg-RX-API-DMAC7.html) |
| LT (1) | LT2785368T (cg-RX-API-DMAC7.html) |
| RS (1) | RS58919B1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2785368T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013082558A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2785368B1 (en) | 2011-12-02 | 2019-03-13 | Integrated Biotherapeutics, Inc. | Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| EP3441474B1 (en) * | 2013-06-18 | 2020-07-22 | New York University | Pharmaceutical compositions containing a mutated leukocidin e |
| PT3010535T (pt) | 2013-06-19 | 2020-07-03 | Integrated Biotherapeutics Inc | Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões |
| US9149521B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9017698B2 (en) | 2013-09-25 | 2015-04-28 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9149522B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9504743B2 (en) | 2013-09-25 | 2016-11-29 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| RU2016119052A3 (en) * | 2013-10-17 | 2018-09-10 | Arsanis Biosciences Gmbh | Cross-reactive Staphylococcus aureus antibody sequences |
| WO2017026301A1 (ja) * | 2015-08-10 | 2017-02-16 | 株式会社微生物化学研究所 | 黄色ブドウ球菌不活化菌体とロイコシジンを混合したワクチン |
| CN107224575B (zh) * | 2017-03-06 | 2018-11-09 | 浙江海隆生物科技有限公司 | 奶牛金黄色葡萄球菌乳房炎亚单位疫苗的组合物及其制备方法和应用 |
| US11260120B2 (en) | 2017-07-27 | 2022-03-01 | Integrated Biotherapeutic Vaccines, Inc. | Immunogenic composition comprising a fusion peptide derived from superantigen toxoids |
| WO2025085539A1 (en) * | 2023-10-16 | 2025-04-24 | The Trustees Of Columbia University In The City Of New York | Engineered bacteria for cellular barrier maintenance and protection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US20100158871A1 (en) | 1999-08-30 | 2010-06-24 | David Stephen Terman | Sickled erythrocytes with antitumor molecules induce tumoricidal effects |
| US20050008633A1 (en) | 2003-05-19 | 2005-01-13 | Advanced Inhalation Research Inc. | Chemical and physical modulators of bioavailability of inhaled compositions |
| TWI374892B (en) * | 2005-06-13 | 2012-10-21 | Glaxosmithkline Biolog Sa | Use of panton-valentine leukocidin for treating and preventing staphylococcus infections |
| US7754225B2 (en) | 2006-07-20 | 2010-07-13 | Glaxosmithkline Biologicals S.A. | Method of protecting against staphylococcal infection |
| AU2007310738B2 (en) * | 2006-10-18 | 2013-07-18 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for in vitro diagnosis of PVL-producing Staphylococcus aureus |
| EP2785368B1 (en) | 2011-12-02 | 2019-03-13 | Integrated Biotherapeutics, Inc. | Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
-
2012
- 2012-11-30 EP EP12854165.3A patent/EP2785368B1/en active Active
- 2012-11-30 RS RS20190664A patent/RS58919B1/sr unknown
- 2012-11-30 CA CA2857666A patent/CA2857666C/en active Active
- 2012-11-30 DK DK12854165.3T patent/DK2785368T3/da active
- 2012-11-30 US US14/362,298 patent/US10023848B2/en active Active
- 2012-11-30 AU AU2012345645A patent/AU2012345645B2/en active Active
- 2012-11-30 JP JP2014544964A patent/JP6325452B2/ja active Active
- 2012-11-30 SI SI201231603T patent/SI2785368T1/sl unknown
- 2012-11-30 WO PCT/US2012/067483 patent/WO2013082558A1/en not_active Ceased
- 2012-11-30 HR HRP20190907TT patent/HRP20190907T1/hr unknown
- 2012-11-30 ES ES12854165T patent/ES2728445T3/es active Active
- 2012-11-30 LT LTEP12854165.3T patent/LT2785368T/lt unknown
- 2012-11-30 KR KR1020147018356A patent/KR101999299B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015505831A5 (cg-RX-API-DMAC7.html) | ||
| CA2873272C (en) | Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof | |
| DK3110438T3 (en) | USPA2 PROTEIN CONSTRUCTS AND APPLICATIONS THEREOF | |
| JP7072921B2 (ja) | Ａ群レンサ球菌ワクチン | |
| KR20210088535A (ko) | 폐렴구균 융합 단백질 백신 | |
| Jing et al. | Oligomerization of IC43 resulted in improved immunogenicity and protective efficacy against Pseudomonas aeruginosa lung infection | |
| EP3833387A1 (en) | Compositions and methods for preventing and treating virus infection | |
| ES2367128T3 (es) | Procedimiento para preparar una variante del antígeno protector de superficie de erysipelothrix rhusiopathiae en e. coli. | |
| US10933126B2 (en) | Clostridium difficile immunogenic compositions and methods of use | |
| US20250281591A1 (en) | Staphylococcus aureus vaccine compositions | |
| JP2021505525A (ja) | Ａ群レンサ球菌に対する免疫原性ペプチド | |
| WO2022067255A2 (en) | Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositions | |
| TW201347770A (zh) | 致熱原性外毒素ｂ胜肽疫苗 | |
| RU2775621C2 (ru) | Иммуногенный пептид против стрептококков группы а | |
| CN117355328A (zh) | 金黄色葡萄球菌疫苗组合物 | |
| US20190276502A1 (en) | Fusion polypeptides derived from staphylococcus aureus antigens | |
| EP3535281A1 (en) | Fusion polypeptides |